Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Technical Report
Nature Medicine - 12, 1323 - 1328 (2006)
Published online: 29 October 2006; | doi:10.1038/nm1420

A male contraceptive targeting germ cell adhesion

Dolores D Mruk1, Ching-Hang Wong1, Bruno Silvestrini2 & C Yan Cheng1

1  Population Council, Center for Biomedical Research, 1230 York Avenue, New York, New York 10021, USA.

2  University of Rome 'La Sapienza', P. Le Aldo Moro 5, 00185, Rome, Italy.

Correspondence should be addressed to C Yan Cheng y-cheng@popcbr.rockefeller.edu or Dolores D Mruk d-mruk@popcbr.rockefeller.edu

Throughout spermatogenesis, developing germ cells remain attached to Sertoli cells via testis-specific anchoring junctions. If adhesion between these cell types is compromised, germ cells detach from the seminiferous epithelium and infertility often results. Previously, we reported that Adjudin is capable of inducing germ cell loss from the epithelium. In a small subset of animals, however, oral administration of Adjudin (50 mg per kg body weight (b.w.) for 29 d) resulted in adverse effects such as liver inflammation and muscle atrophy. Here, we report a novel approach in which Adjudin is specifically targeted to the testis by conjugating Adjudin to a recombinant follicle-stimulating hormone (FSH) mutant, which serves as its 'carrier'. Using this approach, infertility was induced in adult rats when 0.5 mug Adjudin per kg b.w. was administered intraperitoneally, which was similar to results when 50 mg per kg b.w. was given orally. This represents a substantial increase in Adjudin's selectivity and efficacy as a male contraceptive.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

REVIEWS

A local autocrine axis in the testes that regulates spermatogenesis

Nature Reviews Endocrinology Review (01 Jul 2010)

Mouse models of male infertility

Nature Reviews Genetics Review (01 Oct 2002)

See all 18 matches for Reviews

NEWS AND VIEWS

Hormonal control of spermatogenesis

Nature News and Views (13 Mar 1975)

Contraception: Switching Off the Male

Nature News and Views (22 Dec 1972)

See all 4 matches for News And Views
 Top
Abstract
Previous
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
CrossRef lists 45 articles citing this articleCrossRef lists 45 articles citing this article
Save this linkSave this link
Supplementary info
Export citation

natureevents

natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy